SURFACE PHENOTYPE AND IMMUNOGLOBULIN HEAVY-CHAIN GENE USAGE OF B-CLL - EXPRESSION OF MYELOMONOCYTIC MARKERS IN CD5 NEGATIVE B-CLL

被引：0
|
作者：
NIHO, Y
IKEMATSU, W
IKEMATSU, H
OHTSUKA, T
HARADA, M
OKAMURA, S
机构：
[1] KYUSHU UNIV,CTR CANC,DEPT INTERNAL MED 1,FUKUOKA,JAPAN
[2] KYUSHU UNIV,DEPT GEN MED,FUKUOKA,JAPAN
来源：
EXPERIMENTAL HEMATOLOGY | 1993年 / 21卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1090 / 1090
页数：1
相关论文
共 50 条
  • [11] CD5 negative (-) chronic B cell leukemias are rarely classifiable as B cell chronic lymphocytic leukemia (B-CLL)
    Huang, JC
    Finn, WG
    Variakojis, D
    Goolsby, CL
    Peterson, LC
    LABORATORY INVESTIGATION, 1997, 76 (01) : 742 - 742
  • [12] LONG SURVIVAL IN B-CLL CORRELATES WITH SURFACE IGMK PHENOTYPE
    HAMBLIN, TJ
    OSCIER, DG
    STEVENS, JR
    SMITH, JL
    BRITISH JOURNAL OF HAEMATOLOGY, 1987, 66 (01) : 21 - 26
  • [13] Gene expression profiling suggests that B-CLL B cells from only a subset of B-CLL patients derive from CD5+CD19+ peripheral B-cells.
    Messmer, D
    Messmer, BT
    Allen, SL
    Kolitz, J
    Vinciguerra, V
    Rai, KR
    Chiorazzi, N
    BLOOD, 2001, 98 (11) : 149A - 149A
  • [14] Immunoglobulin (Ig) variable gene usage, mutation patterns and heavy (HQ and light chain (LC) pairings in B cell chronic lymphocytic leukemia (B-CLL).
    Stamatopoulos, K
    Belessi, C
    Kyriazopoulos, P
    Hadzidimitriou, A
    Smilevska, T
    Stavroyiatini, N
    Papadaki, T
    Tsompanakou, A
    Paterakis, G
    Valianatou, K
    Athanasiadou, A
    Kokkini, G
    Athanasiadou, L
    Marinakis, T
    Sotiropoulos, D
    Saloum, R
    Laoutaris, N
    Anagnostopoulos, A
    Fassas, A
    BLOOD, 2003, 102 (11) : 671A - 671A
  • [15] CD26 (dipedtidyl peptidase IV) expression in B-CLL
    Galligan, Leeona
    Catherwood, Mark A.
    Morris, Treen C.
    Alexander, H. Denis
    BLOOD, 2007, 110 (11) : 248B - 248B
  • [16] Aberrant Zap-70 expression; A cause of the anergic phenotype in B-CLL?
    O'Connor, SJM
    Teasdale, J
    Tooze, R
    Owen, RG
    Hillmen, P
    Jack, AS
    BLOOD, 2002, 100 (11) : 379A - 380A
  • [17] CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients
    Perez-Chacon, Gema
    Vargas, Juan A.
    Jorda, Julia
    Alvarez, Natalia
    Martin-Donaire, Trinidad
    Rosado, Silvia
    Losada-Fernandez, Ignacio
    Rebolleda, Nerea
    Perez-Aciego, Paloma
    LEUKEMIA & LYMPHOMA, 2007, 48 (01) : 147 - 157
  • [18] Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a northeastern region of Italy
    Donisi, Pietro Maria
    Di Lorenzo, Nadia
    Riccardi, Manuela
    Paparella, Alessandro
    Sarpellon, Claudia
    Zupo, Simona
    Bertoldero, Giovanni
    Minotto, Claudia
    Stracca-Pansa, Vincenzo
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2006, 15 (04) : 206 - 215
  • [19] Immunoglobulin (Ig) VH gene usage in B-CLL patients: Different VH gene profiles in unmutated compared to mutated CLL and normal controls.
    Duke, V
    Gandini, D
    Sherrington, P
    Lin, K
    Heelan, B
    Prentice, G
    Hoffbrand, V
    Foroni, L
    BLOOD, 2001, 98 (11) : 282B - 282B
  • [20] The effect of the B-CLL microenvironment on CD38 expression by the malignant clone
    Patten, P. E. M.
    Buggins, A. S. G.
    Richards, J.
    Wotherspoon, A.
    Salisbury, J.
    Hamblin, T.
    Mufti, G. J.
    Devereux, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 194 - 194
12345